# ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease

> **NCT03622905** · NA · COMPLETED · sponsor: **Functional Neuromodulation Ltd** · enrollment: 74 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DEVICE:** DBS-f On
- **DEVICE:** DBS Off

## Key facts

- **NCT ID:** NCT03622905
- **Lead sponsor:** Functional Neuromodulation Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2024-02-19
- **Final completion:** 2024-02-19
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03622905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03622905, "ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03622905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*